French medical device startups selected for business support

Seven French medical device start-ups have been selected to receive business support by a programme designed to immerse healthcare start-ups in Israel’s tech and healthcare network.

The French Tech Tour Healthcare Israel selected the seven businesses to confirm their development potential, create technology partnerships and offer experience within the market. The programme was started in 2016 by Business France, Bpifrance and the Medicen Paris Region healthcare business cluster.

The companies will receive support for three months which includes a one-week workshop in Tel Aviv Israel.

Israel is regarded as one of the most active sectors for life sciences. In 2015 Israeli high-tech companies earned €4.4 billion, 22% of which was the total for the life sciences sector alone.

The winners embarked on the three month support programme at the end of April. The companies were hosted at HUB Bpifrance where they received training in Israeli business practices and culture, were given an introduction to pitching and were taught how to protect their intellectual property.

To help increase their visibility in Israel the companies wil be present in the France pavilion at the BioMed Israel conference. There they will be given special access to a host of companies and will engage in one-to-one meetings with entrepreneurs.

François Matraire, head of Business France Israel said: “French start-ups specialised in healthcare absolutely have to consider the opportunities offered by Israel to achieve their worldwide aims. First and foremost, Israel is a market with plenty of openings for French high-tech solutions. The country is also one of the best launch pads in the world for accessing funding, developing collaborative R&D projects and creating strategic partnerships. This opens up exciting opportunities for an international launch. The French Tech Tour Healthcare Israel event is an unprecedented catalyst for all these kinds of cross-disciplinary partnerships, designed to open up the global healthcare market.”

The seven start-ups selected for FTT Healthcare Israel 2017 include:

Cardiawave - Develops a non-invasive medical device for real-time, image-guided ultrasound therapy for calcific aortic stenosis.

Cardiorenal - Aims to improve the medical treatment of patients with severe heart failure. A lab facility is placed in the patient’s home, this expert system collects medical data and supports appropriate treatment recommendations.

Eukarys - Developing a new type of genetic medicine – known as synthetic gene therapy – based on its C3P3 artificial expression system, which synthesises messenger RNA and/or inhibitory RNA sequences in the cytoplasm of eukaryotic cells. The pipeline of treatments in development is targeting severe monogenic liver diseases and frequently occurring multifactorial diseases

Neurallys - Developing an intelligent sensor, which continuously measures intracranial pressure in hydrocephalus outpatients who have an implanted shunt system. This helps to detect valve malfunctions and thereby improves patients’ everyday comfort and avoids exploratory surgical intervention.

Osseomatrix - Advancing the treatment of bone loss with 3D printing technology for synthetic bones, made to measure from patients’ scan images.

Qalyo - Develops a smartphone app to support individuals who are in good health, at risk or already ill. The combination of the modular, intuitive structure of the software and data analyses with a medical slant allows physicians, pharmacists, hospitals and pharmaceutical companies to monitor their patients.

Qynapse - Markets a technology to predict clinical progression and measure the efficacy of treatments in diseases of the central nervous system. The software helps pharmaceutical companies to conduct better-targeted clinical trials and to provide clinicians with a decision-making tool for targeting and measuring.